Because etanercept is used to treat rheumatoid arthritis, rather than heart failure, it is possible that it has poor bio‐distribution into cardiac tissues and may not block locally produced TNF‐α (Mann et al., 2008). The gene discussed is TNF; the disease is heart failure.